Regeneron Pharmaceuticals (REGN)
Revenue
$16.90B
TTM · Period ending: · USD
REGN Revenue
Latest reported$16.90Bperiod ending
Latest reported$16.90Bperiod ending
REGN Revenue ($5.00M → $16.90B)
Annual revenue
High-resolution chart · PNG
REGN revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Revenue (USD) |
|---|---|
| 14,342,900,000 | |
| 14,202,000,000 | |
| 13,117,200,000 | |
| 12,172,900,000 | |
| 16,071,700,000 | |
| 8,497,100,000 | |
| 6,557,600,000 | |
| 6,710,800,000 | |
| 5,872,227,000 | |
| 4,860,427,000 | |
| 4,103,728,000 | |
| 2,819,557,000 | |
| 2,104,745,000 | |
| 1,378,477,000 | |
| 445,824,000 | |
| 459,074,000 | |
| 379,268,000 | |
| 238,457,000 | |
| 125,024,000 | |
| 63,447,000 | |
| 66,193,000 | |
| 174,017,000 | |
| 57,497,000 | |
| 21,988,000 | |
| 21,973,000 | |
| 59,276,000 | |
| 34,500,000 | |
| 38,200,000 | |
| 33,100,000 | |
| 24,100,000 | |
| 27,400,000 | |
| 23,200,000 | |
| 10,600,000 | |
| 11,500,000 | |
| 7,300,000 | |
| 5,000,000 |